Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Quanterix CorporationNASDAQ: QTRX
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation outflow shrinks to $0
Q1 FY2026 stock-based compensation was $0, compared with $5.46M a year earlier. Trailing-twelve-month stock-based compensation was $9.79M. Over 3 fiscal years it compounded at +10.3% a year.
Context
- Stock-based compensation amounted to 14.9% of revenue in FY2025, up 0.2 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $2.45M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 20.72M USD
- Year-over-year change
- +3.7%
- 4-year CAGR
- +6.7%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20.72M | +3.7% |
| FY2024 | 2024-12-31 | 19.99M | +19.2% |
| FY2023 | 2023-12-31 | 16.76M | +8.6% |
| FY2022 | 2022-12-31 | 15.44M | -3.3% |
| FY2021 | 2021-12-31 | 15.98M | — |
Stock-Based Compensation vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's LTM Mar 2026 stock-based compensation of $9.79M is the 6th largest of the 11 companies compared; the peer median is $9.58M.
- Its year-over-year change of +79.2% is the highest of 11, against a peer median of -22.3%.
- Stock-based compensation amounts to 6.8% of revenue for QTRX, versus a peer median of 14.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $16.09M | -33.3% | -16.9% | 13.7% | |
| LTM Mar 2026 | $11.67M | -30.6% | +0.2% | 14.7% | |
| LTM Mar 2026 | $11.51M | +11.1% | +41.7% | 19.5% | |
| LTM Mar 2026 | $10.59M | +14.3% | +5.6% | 26.0% | |
| LTM Mar 2026 | $9.88M | -14.0% | +11.0% | 17.1% | |
| LTM Mar 2026 | $9.79M | +79.2% | +10.3% | 6.8% | |
| LTM Mar 2026 | $9.27M | +29.4% | +20.6% | 3.2% | |
| LTM Mar 2026 | $7.82M | +9.7% | -13.3% | 2.2% | |
| LTM Dec 2025 | $4.19M | -42.3% | -39.2% | 32.2% | |
| LTM Mar 2026 | $2.38M | -344.3% | — | 5.4% | |
| LTM Mar 2026 | $1.52M | -69.5% | — | — | |
| Peer median (excluding QTRX) | $9.58M | -22.3% | +2.9% | 14.7% | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (57.69M) | (96.7M) | (32.33M) | (38.53M) | (107.15M) |
| Depreciation & Amortization | 4.85M | 5.35M | 8.38M | 8.36M | 18.93M |
| Deferred Income Tax | 801K | (226K) | 0 | 0 | (5.87M) |
| Stock-Based Compensation | 15.98M | 15.44M | 16.76M | 19.99M | 20.72M |
| Change in Working Capital | (12.19M) | 2.07M | (11.8M) | (18.79M) | (2.35M) |
| Accounts Receivables | (6.85M) | 5.16M | (6.7M) | (7.7M) | 10.61M |
| Inventory | (8.09M) | 5.39M | (5.36M) | (6.68M) | 4.03M |
| Accounts Payables | 2.41M | (5.36M) | 1.19M | 723K | (528K) |
| Other Working Capital | 343K | (3.11M) | (933K) | (5.13M) | (16.47M) |
| Other Non-Cash Items | 340K | 25.79M | 92K | (6.19M) | (1.51M) |
| Operating Cash Flow | (47.91M) | (48.27M) | (18.9M) | (35.16M) | (77.24M) |
| Capital Expenditures | (13.62M) | (11.73M) | (3.79M) | (3.37M) | (2.61M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (93.23M) |
| Purchases of Investments | 0 | 0 | (175.61M) | (295.61M) | (69.76M) |
| Sales of Investments | 0 | 0 | 31M | 216.71M | 215.83M |
| Other Investing Activities | 7.28M | 520K | 0 | 0 | 0 |
| Investing Cash Flow | (6.34M) | (11.21M) | (148.4M) | (82.27M) | 50.23M |
| Debt Repayment | (7.74M) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 269.72M | 2.31M | 2.89M | 3.07M | 738K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 8.82M | 0 | (198K) | (2.61M) | (1.45M) |
| Financing Cash Flow | 270.8M | 2.31M | 2.69M | 456K | (708K) |
| Effect of Forex Changes | (92K) | (538K) | 301K | (734K) | 1.57M |
| Net Change in Cash | 216.46M | (57.71M) | (164.31M) | (117.71M) | (26.14M) |
| Free Cash Flow | (61.52M) | (60M) | (22.69M) | (38.53M) | (79.85M) |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.